Komunikace s handicapovanými

prof. ThLic. MUDr. Květoslav Šipr, CSc.

Urol. praxi, 2015; 16(3)  

Urolithiasis and obesity

MUDr.Peter Dančík, MUDr.Jana Povová, Ph.D., Mgr.Kateřina Vařechová, prof.MUDr.Vladimír Janout, CSc.

Urol. praxi, 2015; 16(3): 99-101  

Obesity represents one of today´s most serious health problems. It causes or it participates with other factors to the higher occurence of urolithiasis. The determining metabolical factor leading to the higher prevalence of urolithiasis is low urine pH, which causes lower solubility of uric acid. Its crystals function as promoters of oxalate lithiasis creation or directly to the creation of urate lithiasis. The therapy of urolithiasis in obese patients is by introduction of modern endoscopic methods very safe and effective in spite of certain specifics in obese patients.

Urinary tract infection in children: a nephrologist’s perspective

MUDr.Hana Flögelová

Urol. praxi, 2015; 16(3): 102-105  

Review of the urinary tract infection in children which focuses on the guidelines for urologists, pediatricians and general pediatricians. This article deals with clinical manifestations of the urinary tract infection, which are in different age categories significantly different. The necessary examinations for a correct diagnose are given. Initial antibiotic therapy is recommended and the need for hospitalization is discussed. Finally, appropriate imaging examinations are listed during and after the urinary tract infection and possibilities of prevention.

Benefit (-2)proPSA and PHI for the diagnosis of prostate cancer

MUDr.Josef Kopecký, MUDr.Jana Povová, Ph.D., prof.MUDr.Vladimír Janout, CSc.

Urol. praxi, 2015; 16(3): 106-108  

The benefits of prostate-specific antigen (PSA) and its isoforms for the early diagnosis of prostate cancer (CaP) are considered with respect to overdiagnosis and overtreatment. From the available literature it is evident that isoform (-2)proPSA and calculated prostate health index (PHI) have greater sensitivity and specificity for the diagnosis of CaP with PSA levels of 2.0 – 10,0 ng/ml, than the determination of total PSA (tPSA) free (fPSA), and their ratio. The implementation and expansion of PHI into clinical practice therefore, could lead to a reduction of prostatic biopsy and overdiagnosis. Only some of the work showed a significant...

Effect of myo-inositol and antioxidants on male fertility

MUDr.Lukáš Bittner, FEBU, FECSM

Urol. praxi, 2015; 16(3): 109-112  

Infertility is a problem that affects large number of pairs. Treatment of male factor is arduous, especially in the case of idiopathic causes of infertility. Inositol is a promising agent improving quality of sperm, which effectiveness demonstrates recent studies. Oxidative stress reduction remains one of the pillars in treatment of idiopathic male infertility.

Vasectomy - „new” option in male contraception

MUDr.Jindřich Šonský, MUDr.Lukáš Bittner, FEBU, FECSM, doc.MUDr.Robert Grill Ph.D., MHA

Urol. praxi, 2015; 16(3): 113-115  

Vasectomy is a highly effective method of contraception. With the development of no-scalpel technique, significant percentage of couples worldwide rely on it. In 2012 the Czech Republic has changed its legal legislation restricting the use of vasectomy, which is easily accessible now. Its advantages are its minimal invasiveness, low risk of complications and high reliability.

Human papillomavirus

MUDr.Martina Poršová, MUDr.Jaroslav Porš, MUDr.Ivan Kolombo, FEBU

Urol. praxi, 2015; 16(3): 116-120  

Infections caused by the human papillomaviruses (HPV) are the most common sexually transmitted diseases worldwide (1). A papillomavirus infection is encountered by more than a half of sexually active men and women at some point in their lives. Only about 1% of anogenital HPV infections (particularly types 6 and 11) are clinically manifested and can result in developing macroscopically distinct lesions (condylomata acuminata). Certain HPV types can induce the development of dysplastic or malignant changes. Only symptomatic visible lesions are treated in patients. There are a number of treatment options, with their choice being driven by the...

Multiple ureteritis cystica: a pseudotumour lesion

MUDr.Miroslav Louda, Ph.D., doc.MUDr.Miloš Broďák, Ph.D., MUDr.Jaroslav Pacovský, MUDr.Michal Balík, MUDr.Slavomír Vachata, MUDr.Lukáš Holub, MUDr.Vladimír Giblo, MUDr.Miroslav Podhola, Ph.D.

Urol. praxi, 2015; 16(3): 121-122  

In the case is presented bilateral ureteritis cystica. 77-years old woman, which underwent radical cystectomy. A case of intraoperative finding of benign pseudotumor of ureter.

Osteosarcoma of the urinary bladder in a patient after prolonged adjuvant therapy for primary urothelial bladder carcinoma

MUDr.Miroslav Louda, Ph.D., MUDr.Miloslav Podhola, Ph.D., MUDr.Jaroslav Pacovský, Ph.D., MUDr.Vladimír Giblo, Ph.D.

Urol. praxi, 2015; 16(3): 124-126  

We report a rare occurrence of primary osteosarcoma of the urinary bladder in a patient originally under surveillance for superficial urothelial bladder carcinoma, pT1NoMo G II. This multimorbid 74-year-old patient had been treated for intermittent recurrence of urothelial carcinoma for 13 years and had been unsuitable for radical cystectomy. The patient underwent systemic chemotherapy for early multiple recurrence of carcinoma in 1997; due to further recurrence, radiotherapy to the pelvic area was delivered. Due to further recurrences with low grading, the patient received repeated local chemotherapy lavage with mitomycin monthly, 12 times in...

Prevention of urinary incontinence in the elderly

Mgr.Pavla Drábková

Urol. praxi, 2015; 16(3): 127-129  

Urinary incontinence is a major health and social problem. It affects all individuals regardless of age or social status. It is true, however, that incidence and prevalence of this disease is increasing due to the growing senior population. Therefore, it is always a current topic. Every disease and symptom can be prevented, and urinary incontinence is not an exception. Prevention is an integral part of the task of health workers in the educational process and patient education.

3. český video- kongres - zpráva z proběhlé akce

doc.MUDr.Miloš Broďák, Ph.D.

Urol. praxi, 2015; 16(3): 134  

Urologie v loňském roce: po delší době průlom ve farmakoterapii a hned trojnásobný!

Urol. praxi, 2015; 16(3): 130-132